Annual CFI
-$1.16 M
-$986.00 K-552.69%
March 1, 2024
Summary
- As of February 24, 2025, VRAX annual cash flow from investing activities is -$1.16 million, with the most recent change of -$986.00 thousand (-552.69%) on March 1, 2024.
Performance
VRAX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VRAX Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -552.7% | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
VRAX Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | <-9999.0% | at low | ||||
5 y | 5-year | <-9999.0% | at low | ||||
alltime | all time | <-9999.0% | at low |
Virax Biolabs Group Limited Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | -$1.16 M(+552.7%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | -$178.40 K(<-9900.0%) | - | - |
Mar 2022 | $0.00 | - | - |
FAQ
- What is Virax Biolabs Group Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual CFI year-on-year change?
What is Virax Biolabs Group Limited annual cash flow from investing activities?
The current annual CFI of VRAX is -$1.16 M
What is the all time high annual CFI for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual cash flow from investing activities is $0.00
What is Virax Biolabs Group Limited annual CFI year-on-year change?
Over the past year, VRAX annual cash flow from investing activities has changed by -$986.00 K (-552.69%)